A phase II clinical trial of ganetespib (STA-9090) in previously treated patients with advanced esophagogastric cancers

被引:0
|
作者
Kwak, Eunice Lee
Goyal, Lipika
Abrams, Thomas Adam
Carpenter, Amanda
Wolpin, Brian M.
Wadlow, Raymond Couric
Allen, Jill N.
Heist, Rebecca Suk
McCleary, Nadine Jackson
Chan, Jennifer A.
Goessling, Wolfram
Schrag, Deborah
Evans, Colleen
Ng, Kimmie
Enzinger, Peter C.
Ryan, David P.
机构
[1] Massachusetts Gen Hosp Canc Ctr, Div Hematol & Oncol, Boston, MA USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] Massachusetts Gen Hosp Canc Ctr, Boston, MA USA
[5] Virginia Canc Specialists, Fairfax, VA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4090
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Phase II trial of oral rubitecan in previously treated pancreatic cancer patients
    Burris, HA
    Rivkin, S
    Reynolds, R
    Harris, J
    Wax, A
    Gerstein, H
    Mettinger, KL
    Staddon, A
    ONCOLOGIST, 2005, 10 (03): : 183 - 190
  • [42] TENIPOSIDE IN RECURRENT OR ADVANCED CERVICAL-CARCINOMA - A PHASE-II TRIAL IN PATIENTS NOT PREVIOUSLY TREATED WITH CYTOTOXIC THERAPY
    PFEIFFER, P
    COLD, S
    BERTELSEN, K
    PANDURO, J
    SANDBERG, E
    ROSE, C
    GYNECOLOGIC ONCOLOGY, 1990, 37 (02) : 230 - 233
  • [43] A phase II trial of ixabepilone in Asian patients with advanced gastric cancer previously treated with fluoropyrimidine-based chemotherapy
    Yeul Hong Kim
    Kei Muro
    Hirofumi Yasui
    Jen-Shi Chen
    Min-Hee Ryu
    Se-Hoon Park
    Kent-Man Chu
    Su-Pin Choo
    Teresa Sanchez
    Christine DelaCruz
    Pralay Mukhopadhyay
    Ioannis Lainas
    Chung-Pin Li
    Cancer Chemotherapy and Pharmacology, 2012, 70 : 583 - 590
  • [44] Rationale of a Phase II Trial of Nivolumab Combined with Anlotinib in Advanced NSCLC Previously Treated with Immunotherapy
    Han, B.
    Zhang, B.
    Shi, C.
    Gao, Z.
    Zhong, H.
    Xiong, L.
    Gu, A.
    Wang, W.
    Chu, T.
    Zhang, W.
    Wang, H.
    Zhang, X.
    Zhong, R.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S679 - S680
  • [45] A phase II trial of ixabepilone in Asian patients with advanced gastric cancer previously treated with fluoropyrimidine-based chemotherapy
    Kim, Yeul Hong
    Muro, Kei
    Yasui, Hirofumi
    Chen, Jen-Shi
    Ryu, Min-Hee
    Park, Se-Hoon
    Chu, Kent-Man
    Choo, Su-Pin
    Sanchez, Teresa
    DelaCruz, Christine
    Mukhopadhyay, Pralay
    Lainas, Ioannis
    Li, Chung-Pin
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (04) : 583 - 590
  • [46] A Phase II Trial of Denileukin Diftitox in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer
    Gerena-Lewis, Margie
    Crawford, Jeffrey
    Bonomi, Philip
    Maddox, Ann Marie
    Hainsworth, John
    McCune, David E.
    Shukla, Rakesh
    Zeigler, Haoyue
    Hurtubise, Paul
    Chowdhury, Tracy R.
    Fletcher, Brandon
    Dyehouse, Karyn
    Ghalie, Richard
    Jazieh, Abdul R.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009, 32 (03): : 269 - 273
  • [47] Phase II trial of oral piritrexim in advanced, previously treated transitional cell cancer of bladder
    Masoud Khorsand
    Joan Lange
    Lynn Feun
    Neil J. Clendeninn
    Mary Collier
    George Wilding
    Investigational New Drugs, 1997, 15 : 157 - 163
  • [48] Phase II trial of oral piritrexim in advanced, previously treated transitional cell cancer of bladder
    Khorsand, M
    Lange, J
    Feun, L
    Clendeninn, NJ
    Collier, M
    Wilding, G
    INVESTIGATIONAL NEW DRUGS, 1997, 15 (02) : 157 - 163
  • [49] A PHASE-II TRIAL OF IPROPLATIN (CHIP) IN PREVIOUSLY TREATED ADVANCED BREAST-CANCER
    MEISNER, DJ
    GINSBERG, S
    DITCH, A
    LOUIE, A
    NEWMAN, N
    COMIS, R
    POIESZ, B
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1989, 12 (02): : 129 - 131
  • [50] A Phase II Trial of Pevonedistat and Docetaxel in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer
    Qin, Angel
    Wells, Leah
    Malhotra, Binu
    Gadgeel, Shirish
    Schneider, Bryan J.
    Ramnath, Nithya
    Rice, John D.
    Kalemkerian, Gregory P.
    CLINICAL LUNG CANCER, 2024, 25 (02) : 128 - 134